Edwards Lifesciences Corp. (EW)
90.76
+0.56
(+0.62%)
USD |
NYSE |
Aug 31, 16:00
90.76
0.00 (0.00%)
After-Hours: 20:00
Edwards Lifesciences Cash from Operations (TTM) : 1.720B for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.720B |
| March 31, 2026 | 1.359B |
| December 31, 2025 | 1.595B |
| September 30, 2025 | 1.017B |
| June 30, 2025 | 794.90M |
| March 31, 2025 | 876.20M |
| December 31, 2024 | 542.30M |
| September 30, 2024 | 806.40M |
| June 30, 2024 | 866.10M |
| March 31, 2024 | 528.20M |
| December 31, 2023 | 895.80M |
| September 30, 2023 | 1.042B |
| June 30, 2023 | 940.40M |
| March 31, 2023 | 1.239B |
| December 31, 2022 | 1.218B |
| September 30, 2022 | 1.309B |
| June 30, 2022 | 1.531B |
| March 31, 2022 | 1.725B |
| December 31, 2021 | 1.732B |
| September 30, 2021 | 1.758B |
| June 30, 2021 | 1.443B |
| March 31, 2021 | 1.148B |
| December 31, 2020 | 1.054B |
| September 30, 2020 | 1.054B |
| June 30, 2020 | 1.275B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.385B |
| December 31, 2019 | 1.179B |
| September 30, 2019 | 1.073B |
| June 30, 2019 | 978.00M |
| March 31, 2019 | 777.00M |
| December 31, 2018 | 926.80M |
| September 30, 2018 | 997.70M |
| June 30, 2018 | 966.20M |
| March 31, 2018 | 1.024B |
| December 31, 2017 | 1.001B |
| September 30, 2017 | 837.90M |
| June 30, 2017 | 733.00M |
| March 31, 2017 | 725.60M |
| December 31, 2016 | 704.40M |
| September 30, 2016 | 607.10M |
| June 30, 2016 | 603.70M |
| March 31, 2016 | 583.50M |
| December 31, 2015 | 549.70M |
| September 30, 2015 | 539.10M |
| June 30, 2015 | 348.80M |
| March 31, 2015 | 956.70M |
| December 31, 2014 | 1.022B |
| September 30, 2014 | 1.040B |
| June 30, 2014 | 1.175B |
| March 31, 2014 | 524.30M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Stryker Corp. | 5.525B |
| Intuitive Surgical, Inc. | 3.706B |
| Abbott Laboratories | 9.905B |
| Zimmer Biomet Holdings, Inc. | 1.743B |
| Solventum Corp. | 209.00M |